Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Investor Presentation

Every investor presentation filing by a US-listed company that our alert engine sent, newest first.

9:05 AM ET 8-K
Investor Presentation Plumas Bancorp PLBC

Plumas Bancorp Investor Presentation

Plumas Bancorp has prepared a formal investor presentation deck to be used in future meetings with investors and analysts. The presentation, filed under Item 7.01, provides strategic highlights and operational information about the company as of October 21, 2026.

9:01 AM ET 8-K
Investor Presentation Inmune Bio, Inc. INMB

Inmune Bio Investor Presentation

INmune Bio filed a formal investor presentation deck and announced a Master Services Agreement with Uniphar to establish a commercialization framework for Ebstrocel. The partnership will initially focus on named-patient access in Europe and the MENA region, providing a capital-efficient infrastructure for international distribution. Additionally, the company submitted a pre-Marketing Authorisation Application to the UK MHRA for Ebstrocel.

Counterparty
Uniphar Durbin Ireland Limited
8:03 AM ET 8-K
Investor Presentation Zedge, Inc. ZDGE

Zedge Investor Presentation

Zedge, Inc. filed a formal investor presentation deck to be used at an upcoming investor conference, highlighting its strategic shift toward its 'DataSeeds' B2B AI data business. The presentation outlines growth opportunities in AI training datasets and provides pro-forma financial highlights, including approximately $27.4 million in cash and zero debt.

6:02 AM ET 8-K
Investor Presentation PDS Biotechnology Corp PDSB

PDS Biotechnology Investor Presentation

PDS Biotechnology updated its corporate presentation deck for October 2026, providing an overview of its oncology drug development programs. The presentation includes updates on its Versamune-based product candidates, including PDS0101 and PDS0301, and discusses the company's research and development strategy.

5:26 PM ET 8-K
Investor Presentation Jefferies Financial Group Inc. JEF

Jefferies Financial Group Investor Presentation

Jefferies Financial Group Inc. held its 2026 Annual Investor Meeting (Investor Day) to discuss the company's strategic growth, scale, and future profitability targets. CEO Rich Handler highlighted the firm's unique market position, its focus on human capital, and the alignment of management and employees who collectively own approximately 40% of the company's shares.

“The strength and scale and scope and capabilities of Jefferies today is something we think is incredibly unique and perhaps not fully understood. We hope to flesh that out a little bit more.”

Rich Handler, CEO

“I'd like to remind everyone in this room, both fellow shareholders, the analysts that cover us, and people on the phone, we're not just a management team at Jefferies. We are also your partners in ownership.”

Rich Handler, CEO
5:01 PM ET 8-K
Investor Presentation Duos Technologies Group, Inc. DUOT

Duos Technologies Group Investor Presentation

Duos Technologies Group, Inc. presented at the 20th Annual LD Micro Main Event on October 20, 2026, and furnished its investor presentation deck. The presentation highlights the company's modular AI colocation business model, including 55 MW in hosting agreements with Axe Compute and a 10 MW agreement with a hyperscaler.

Counterparty
LD Micro
4:26 PM ET 8-K
Investor Presentation Annaly Capital Management Inc NLY

Annaly Capital Management Investor Presentation

Annaly Capital Management filed its Third Quarter 2026 Investor Presentation providing a strategic and operational update. The company reported earnings available for distribution of $0.80 per share, a book value of $17.86 per share, and maintained a liquidity position of $8.5 billion in assets available for financing.

4:06 PM ET 8-K
Investor Presentation Qcr Holdings Inc QCRH

Qcr Holdings Investor Presentation

QCR Holdings, Inc. has posted an updated investor presentation to its corporate website and filed it as an exhibit to the SEC. The presentation provides strategic highlights and financial information for investors and analysts. The filing does not include new quarterly GAAP financial results.

7:47 AM ET 8-K
Investor Presentation Lipocine Inc. LPCN

Lipocine Investor Presentation

Lipocine Inc. has updated its corporate presentation for use in meetings with investors, analysts, and other stakeholders. The presentation was filed as Exhibit 99.1 to the 8-K and provides a strategic overview of the company's business and development pipeline.

7:00 AM ET 8-K
Investor Presentation AIB Data Centers Inc. AIB

AIB Data Centers Investor Presentation

AIB Data Centers Inc. released a formal investor presentation for October 2026 detailing its business strategy as a developer of 40-90 MW data centers for AI and high-performance computing. The presentation includes information on the company's financial position and its Master Colocation Services Agreement with Nebius Inc.

6:56 AM ET 8-K
Investor Presentation Kroger Co KR

Kroger Investor Presentation

Kroger is hosting an Investor Update in New York to outline its multi-year strategic plan and introduce new long-term financial targets through 2029. The company is targeting approximately 3% comparable sales growth, 3%-6% adjusted EBITDA growth, and 7%-11% adjusted net EPS growth, while also reaffirming its full-year 2026 guidance.

“Kroger has a clear opportunity to unlock our full potential and build America’s Favorite Grocer. We are making value more visible and focusing resources closer to the customer where we see the highest returns. With our customers at the center, we are simplifying and modernizing our business to deliver a great customer experience and provide long-term value to our shareholders.”

Greg Foran, CEO of Kroger

“Our financial framework reflects our renewed focus on the core grocery business and provides a clearer line of sight from operating performance to shareholder value. We are targeting higher sales by 2029, with stronger adjusted EBITDA and adjusted EPS growth over the next three years. We remain focused on delivering customer value in a fully self-funded way, prioritizing high-return investments and disciplined cost savings so we can expand margins over time while continuing to invest in growth.”

David Kennerley, CFO of Kroger
5:28 PM ET 8-K
Investor Presentation Phunware, Inc. PHUN

Phunware Investor Presentation

Phunware, Inc. posted an updated investor presentation to its website and announced its participation in the LD Micro 20th Annual Main Event on October 20, 2026. The presentation outlines the company's 'Phunware 2.0' strategy, focusing on its AI-driven Guest Intelligence Platform for hospitality, healthcare, and residential sectors.

4:47 PM ET 8-K
Investor Presentation Usio, Inc. USIO

Usio Investor Presentation

Usio, Inc. filed an updated investor presentation to be delivered at the LD Micro Main Event conference on October 20, 2026, and the Planet MicroCap Toronto Conference on October 28, 2026. The presentation, attached as Exhibit 99.1, provides strategic highlights and business updates for the company's payment processing and fintech solutions.

8:50 AM ET 8-K
Investor Presentation IRulya Therapeutics Inc. IRLA

IRulya Therapeutics Investor Presentation

IRulya Therapeutics Inc. (formerly Quince Therapeutics) has posted its updated Corporate Presentation for October 2026 to its website and filed it as an exhibit. The presentation provides a strategic overview of the company's product candidates, specifically LAM-001, and outlines planned clinical milestones and market opportunities in pulmonary hypertension and related lung diseases.

6:45 AM ET 8-K
Investor Presentation Jefferies Financial Group Inc. JEF

Jefferies Financial Group Investor Presentation

Jefferies Financial Group Inc. filed a formal investor presentation deck as Exhibit 99.1 for its 2026 Investor Meeting held on October 19, 2026. The presentation includes a strategic overview from CEO Rich Handler and President Brian Friedman, along with divisional reviews of investment banking, equities, fixed income, and asset management.

3:43 PM ET 8-K
Investor Presentation Galaxy Gaming, Inc. GLXZ

Galaxy Gaming Investor Presentation

Galaxy Gaming, Inc. posted an updated investor presentation to its website and filed it as an exhibit to its 8-K. The presentation covers the company's Q2 2026 results, its land-based and iGaming business channels, and highlights that 99% of its revenue is recurring.

2:47 PM ET 8-K
Investor Presentation Hawkeye Digital, Inc. HWKE

Hawkeye Digital Investor Presentation

Hawkeye Digital, Inc. (formerly Hawkeye Systems) has released a formal investor presentation outlining its strategic vision to become a leading publicly traded incubator and merchant bank focused on blockchain, digital assets, AI, and fintech. The presentation highlights the company's 'flywheel' strategy of integrating advisory services with its incubator and merchant banking activities.

9:30 AM ET 8-K
Investor Presentation Moleculin Biotech, Inc. MBRX

Moleculin Biotech Investor Presentation

Moleculin Biotech, Inc. has updated its corporate investor presentation and posted the deck to its website. The presentation, filed as Exhibit 99.1, provides a strategic and operational update on the company's clinical pipeline and corporate milestones.

5:26 PM ET 8-K
Investor Presentation Ernexa Therapeutics Inc. ERNA

Ernexa Therapeutics Investor Presentation

Ernexa Therapeutics Inc. has made available a formal investor presentation for October 2026. The presentation is intended to provide strategic updates and company information to investors and is accessible via the company's investor relations website.

5:21 PM ET 8-K
Investor Presentation Semtech Corp SMTC

Semtech Investor Presentation

Semtech Corporation held a Data Center Analyst Day where it raised its third quarter fiscal year 2027 outlook and established a long-term financial framework for fiscal year 2030. The company now expects Q3'27 net sales of $417.5 million and adjusted EPS of $1.14, while targeting $3.2 billion in total net sales by FY2030 driven by significant growth in its data center business.

5:01 PM ET 8-K
Investor Presentation Actelis Networks Inc ASNS

Actelis Networks Investor Presentation

Actelis Networks has published a new corporate investor presentation to its website for use in upcoming conferences and meetings with investors and analysts. The presentation, titled 'Connecting AI To The Edge', focuses on the company's strategy for modernizing Defense, Industrial IoT, and Hospitality sectors.

4:12 PM ET 8-K
Investor Presentation PNC Financial Services Group, Inc. PNC

PNC Financial Services Group Investor Presentation

PNC Financial Services Group filed electronic presentation slides used during its third quarter 2026 earnings conference call. The presentation highlights strong results including $4.97 diluted EPS, solid loan growth, and the return of $1.4 billion to shareholders through dividends and share repurchases.

2:51 PM ET 8-K/A
Investor Presentation KiNRG, Inc. BYOP

KiNRG Investor Presentation

KiNRG, Inc. filed an amended 8-K to furnish a corrected version of its investor presentation, which was originally released on October 14, 2026. The presentation highlights the company's HydroThermal Reactor (HTR) technology designed to provide clean, continuous energy for data centers and industrial operations.

10:28 AM ET 8-K
Investor Presentation Corbus Pharmaceuticals Holdings, Inc. CRBP

Corbus Pharmaceuticals Holdings Investor Presentation

Corbus Pharmaceuticals updated its corporate investor presentation to highlight its clinical pipeline in oncology and obesity. Key focus areas include the CRB-701 Nectin-4 ADC, which is entering a registrational Phase 2 study for OPSCC, and CRB-913, a CB1 inverse agonist for obesity with a Phase 2 study expected to start in the first half of 2027.

8:01 AM ET 8-K
Investor Presentation Ocugen, Inc. OCGN

Ocugen Investor Presentation

Ocugen, Inc. filed a formal investor presentation deck for October 2026 detailing its strategic pipeline and clinical milestones. The company is targeting three Biologics License Applications (BLAs) by 2028 for its gene therapy candidates OCU400, OCU410, and OCU410ST, which address major blindness diseases.

8:01 AM ET 8-K
Investor Presentation SurgePays, Inc. SURG

SurgePays Investor Presentation

SurgePays, Inc. filed an updated corporate investor presentation dated October 2026 to its website and as an exhibit to its 8-K. The presentation provides summary information regarding the company's business operations and corporate profile for investors.

7:00 AM ET 8-K
Investor Presentation i-80 Gold Corp. IAUX

i-80 Gold Investor Presentation

i-80 Gold Corp. announced that it will post an updated corporate presentation to the investors section of its website on October 15, 2026. The presentation provides current strategic and operational highlights for the company's gold mining projects.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.